Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators.
Explore this paper's citation graph
Summary
In patients with a prior myocardial infarction who are at high risk for ventricular tachyarrhythmia, prophylactic therapy with an implanted defibrillator leads to improved survival as compared with conventional medical therapy.
- Type
- article
- Published
- 1996-12-26
- Cited by
- 3,482
- References
- 26
- Access
- Open access
- OpenAlex
- https://openalex.org/W2320382602
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:44537035
Keywords
Medicine, Cardiology, Internal medicine, Hazard ratio, Myocardial infarction
References
- A new electrocardiographic classification for post-myocardial infarction clinical trials.
- Conflict-of-interest guidelines for a multicenter clinical trial of treatment after coronary-artery bypass-graft surgery.
- Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings.
- The automatic implantable cardioverter-defibrillator: efficacy, complications and survival in patients with malignant ventricular arrhythmias.
- Clinical Classification of Cardiac Deaths
- Electrophysiologic testing in patients at high risk for sudden cardiac death. I. Nonsustained ventricular tachycardia and abnormal ventricular function.
- Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial.
- Predictors of First Discharge and Subsequent Survival in Patients With Automatic Implantable Cardioverter‐Defibrillators
- Antiarrhythmic drugs: a possible cause of out-of-hospital cardiac arrest.
- Actuarial Incidence and Pattern of Occurrence of Shocks Following Implantation of the Automatic Implantable Cardioverter Defibrillator
- Electrophysiological testing and nonsustained ventricular tachycardia. Use and limitations in patients with coronary artery disease and impaired ventricular function.
- The automatic implantable cardioverter defibrillator as antiarrhythmic treatment modality of choice for survivors of cardiac arrest unrelated to acute myocardial infarction.
- Pharmacodynamics of intravenous procainamide as used during acute electropharmacologic testing.
- Long-term outcome with the automatic implantable cardioverter-defibrillator.
- Clinical experience, complications, and survival in 70 patients with the automatic implantable cardioverter/defibrillator.
- Clinical Significance of Ventricular Tachycardia (3 Beats or Longer) Detected during Ambulatory Monitoring after Myocardial Infarction
- The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction.
- Antiarrhythmic drugs versus implantable defibrillators: the need for a randomized controlled study.
- Prognostic factors in nonsustained ventricular tachycardia.
- The Design and Analysis of Sequential Clinical Trials (2nd ed.).
Cited by
- Risk stratification following myocardial infarction in the thrombolytic era: a two-step strategy using noninvasive and invasive methods.
- Epidemiology of Arrhythmic and Sudden Death in the Chronic Phase of Ischemic Heart Disease
- Do MADIT results apply only to "MADIT patients"? Multicenter Automatic Defibrillator Implantation Trial.
- Update on implantable cardioverter-defibrillators. New, safer devices have led to changes in indications.
- Current medical therapy for advanced heart failure.
- [Telecardiology--a service performance option for the physician].
- Beta-blockade and amiodarone therapy: twin brothers from different parents.
- Antiarrhythmic drugs or implantable cardioverter defibrillators in heart failure: the "poor heart".
- Has the survival of the heart failure population changed? Lessons from trials.
- Potential benefit of biventricular pacing in patients with congestive heart failure and ventricular tachyarrhythmia.
- Current medical therapy for advanced heart failure.
- Current concepts in secondary prevention after acute myocardial infarction
- Electropharmacologic effect of a standard dose of intravenous procainamide in patients with sustained ventricular tachycardia
- Nonsustained ventricular tachycardia.
- Arrhythmias in heart failure
- Initial clinical experience with a new arrhythmia detection algorithm in dual chamber implantable cardioverter defibrillators.
- Inducible ventricular arrhythmias and patency of infarct‐related artery in survivors of acute myocardial infarction
- Dietary prevention of sudden cardiac death.
- Programmed ventricular stimulation: influence of early versus late introduction of a third extrastimulus, a randomized, prospective study.
- Psychosocial Impact of the Implantable Cardioverter Defibrillator: Nursing Implications
Related papers
- Stratification of sudden death risk in patients receiving long-term amiodarone treatment for sustained ventricular tachycardia or ventricular fibrillation.
- Clinical Predictors of Recurrent Ventricular Arrhythmias in Secondary Prevention Implantable Cardioverter Defibrillator Recipients With Coronary Artery Disease - Lower Left Ventricular Ejection Fraction and Incomplete Revascularization.
- Cardiac magnetic resonance outperforms echocardiography to predict subsequent implantable cardioverter defibrillator therapies in ST-segment elevation myocardial infarction patients
- Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.
- Quantification analysis by delayed enhancement cardiovascular magnetic resonance imaging predicts ventricular arrhythmias in patients with ischemic cardiomyopathy
- Programmed ventricular stimulation for risk stratification in patients with myocardial scarring and an ejection fraction above or equal to 40%
- The role of implantable cardioverter defibrillator for primary vs secondary prevention of sudden death in patients with idiopathic dilated cardiomyopathy.
- Prognostic factors affecting the all-cause death and sudden cardiac death rates of post myocardial infarction patients with low left ventricular ejection fraction.
- Current status and role of programmed ventricular stimulation in patients without sustained ventricular arrhythmias and reduced ejection fraction: Analysis of the Japan cardiac device treatment registry database
- Ablation of ventricular tachycardia: neither inside nor out, thus back to alcohol.